Merck KGaA suffers setback on cancer drug
German pharmaceuticals maker Merck KGaA said Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients.
Jul 5, 2012
0
0
German pharmaceuticals maker Merck KGaA said Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients.
Jul 5, 2012
0
0
An international treaty is a promising tool for improving the coherence, fairness, efficiency, and sustainability of the global health research and development system according to international experts writing in this week's ...
May 15, 2012
0
0
The expert working group advising WHO on research and development has recommended the May 2012 World Health Assembly adopt an international convention on research and development (R&D) that will bind member states to action ...
May 15, 2012
0
0
The prospect of deep cuts in the federal budget threatens to reverse the dramatic progress of a bipartisan US commitment to defeat neglected diseases in developing countries, according to a new report released today by the ...
Feb 28, 2012
0
0
The study identifies the respective contributions of direct and indirect government support in research and development of new pharmaceutical drugs.
Dec 15, 2011
0
0
Nearly three-quarters (74%) of Georgia residents think spending money on research to improve health globally is important for economic development in Georgia, according to a new statewide poll commissioned by Research!America.
Jun 29, 2011
0
0